In 2012, new guidelines emphasized the importance of ENBS covering at least CH, CAH, amino acid metabolism disorders, fatty acid metabolism disorders, GAL, hemoglobinopathies, severe combined immunodeficiency, and other disorders that represent a public health problem (Diario Oficial de la Federación, 2014). The gene discussed is C4B; the disease is hemoglobinopathy.